The SI subunit of pertussis toxin catalyses the hydrolysis of NADI (NADI glycohydrolysis) and the NADI-dependent ADP-ribosylation of guanine-nucleotide-binding proteins. Recently, the SI subunit of pertussis toxin was shown to be photolabelled by using radiolabelled NADI and u.v.; the primary labelled residue was Glu-129, thereby implicating this residue in the binding of NADI. Studies from various laboratories have shown that the N-terminal portion of the SI subunit, which shows sequence similarity to cholera toxin and Escherichia coli heat-labile toxin, is important to the maintenance of both glycohydrolase and transferase activity. In the present study the photolabelling technique was applied to the analysis of a series of recombinant-derived S1 molecules that possessed deletions or substitutions near the N-terminus of the SI molecule. The results revealed a positive correlation between the extent of photolabelling with NADI and the magnitude of specific NADI glycohydrolase activity exhibited by the mutants. Enzyme kinetic analyses of the Nterminal mutants also identified a mutant with substantially reduced activity, a depressed photolabelling efficiency and a markedly increased Km for NADI. The results support a direct role for the N-terminal region of the S1 subunit in the binding of NADI, thereby providing a rationale for the effect of mutations in this region on enzymic activity.
INTRODUCTION
Pertussis toxin (PT) is a hexameric protein toxin produced by Bordetella pertussis that plays a central role in the pathogenesis of pertussis or whooping cough [1] . PT is composed of five different subunits, termed Sl (Mr 28000), S2 (Mr 23000), S3 (Mr 22000), S4 (M, 11 000), and S4 (Mr 9 000) [2] . Most of the pathobiological effects of PT appear to be a consequence of the ability of the SI subunit to catalyse the NADI-dependent ADP-ribosylation of guanine-nucleotide-binding regulatory proteins of the adenylate cyclase complex in eukaryotic cells [3, 4] . PT also appears to be an important component in acellular vaccines against pertussis [5] [6] [7] .
The operon encoding the PT subunits has been cloned and sequenced [8, 9] , and the individual subunit genes have been expressed in Escherichia coli [10] [11] [12] [13] . The isolation and expression of the SI subunit gene has permitted studies designed to identify those regions of the Sl subunit that are important to enzymic activity and that contribute to the formation of potentially important antigenic determinants. Such information would facilitate the production of a non-toxic form of PT that retains protective immunogenicity for use as a potential vaccine constituent. We and others have recently identified a small region of the SI subunit located near the N-terminus (residues [8] [9] [10] [11] [12] [13] [14] in the mature protein) that is required for the expression of detectable enzyme activity [14] [15] [16] [17] . This region also exhibits a high degree of amino acid sequence similarity (identity in seven of eight residues) to sequences found in the N-terminal regions of two other bacterial ADP-ribosylating toxins, cholera toxin (CT) and E. coli heat-labile toxin I (HLT) [8, 9, 18] . Analyses of this region using single-amino-acid substitutions showed that certain replacements could suppress both NADI glycohydrolase and ADP-ribosyltransferase activity without appreciably affecting the reactivity of the S1 subunit with a protective anti-SI monoclonal antibody [15] . Importantly, this antibody has been shown to be directed to a conformational epitope [19] , thus suggesting that the single-amino-acid substitutions did not affect enzyme activity through gross conformational changes. Although these studies suggested that the region delineated by amino acids 8-14 is essential to expression of the enzymic activities of the SI subunit, they did not address the specific function that this region has in the enzymic mechanism.
To help define the specific role of the N-terminal similarity region in the enzymic mechanism, we undertook experiments which were designed to examine the interaction of SI with NAD+ by using photoaffinity-labelling techniques. The experiments were initially prompted by the studies of Collier and co-workers that showed that other ADP-ribosylating toxins, such as diphtheria toxin (DT) and Pseudomonas aeruginosa exotoxin A (ETA), could be specifically labelled with radioactive NADI and u.v. at glutamic acid residues which appeared to be in the vicinity of the active site [20] [21] [22] . The labelling did not require the addition of a photoactivatable group to the NADI, and was postulated to occur through the photoexcitation of one or both of the two nitrogenous bases in the NADI molecule. The studies also identified the labelled amino acids in DT and ETA as Glu-148 and Glu-553 respectively [20, 21] . Substitution of these glutamic acid residues resulted in abrogation of enzyme activity and strongly supported the proposition that they represented active-site residues that were directly involved in NAD+ binding [23, 24] . Recently, both Cockle [25] and Barbieri et al. [26] showed that the purified SI subunit of PT could also be photolabelled by NADI using u.v. irradiation and that the labelling was accompanied by a loss of enzyme activity. The [12, 29] . Assays of total protein were performed by using the bicinchoninic acid method and a reagent kit supplied by Pierce Chemical Co. The recombinant SI molecules constituted 20-40% of the total protein in the preparations.
NAD' glycohydrolase assay NADI glycohydrolase activity was measured as the ability to catalyse the release of nicotinamide from [carbonyl-14C]NAD+ as described previously [12, 16] . Briefly, reaction mixtures (0.05 ml) containing 100 ,sm-ATP, 20 mm-dithiothreitol, 1 termined using Dowex AGI X-2 ion-exchange resin [20] ligand/mol of S1 subunit (Fig. 2) . The maximum amount of incorporation observed after more prolonged labelling (greater than 2h) was approx. 0.7mol of ligand/mol of SI subunit; failure to achieve stoichiometric levels of incorporation may reflect the sensitivity of either the SI subunit or NAD+, or both, to destruction by u.v. light under the conditions employed. Fig.  2 also shows that label was not effectively transferred to the SI subunit from NAD+ containing 14C in the adenine moiety, indicating that only the nicotinamide moiety of NAD+ is covalently linked during the reaction. These results using the purified SI subunit are similar to those reported by Cockle [25] .
In previous work, we described a series of mutant forms of the SI subunit genes that were expressed at high levels in E. coli [15, 16] . These constructs were designed to investigate the potential role of a small N-terminal region of the SI subunit in the expression of enzyme activity. This region, which we previously termed the 'homology box' [16] , spans residues 8-15 in the mature polypeptide and bears considerable sequence similarity (identity in seven of eight residues) to regions located near the Ntermini ofCT and HLT. We found that those molecules truncated beyond amino acid-15, as well as a mutant in which arginine-9 was changed to lysine, lacked detectable NADI glycohydrolase activity [15, 16] .
To examine further the role of the 'homology box' in enzymic activities, we assayed the enzyme kinetic parameters of mutant S1 subunits and their ability to be photolabelled with NADI. When the series of N-terminal deletion and substitution mutants were evaluated in parallel for photolabelling and NAD+ glycohydrolase activity, a general correspondence between the amount of labelling observed after 1 h and relative NADI glycohydrolase activity was observed (Table 1) . It should be noted that the recombinant WT gene encodes an S1 molecule that lacks any vector-derived fusion peptides, but lacks the first two aspartic acid residues of authentic S1 [16] and that all of the mutant subunits, except for rSld, were derived from this construct. In each case where NADI glycohydrolase activity was reduced below reliably detectable limits (less than 5 % of control), the extent of photolabelling was uniformly decreased to less than 10% of that exhibited by the wild-type subunit. Analysis of the reaction products by SDS/PAGE and fluorography revealed that the labelling was confined to the recombinant S1 molecules and was not associated with other contaminating E. coli proteins (results not shown).
The deletion mutant lacking the first six amino acids of the authentic SI subunit (del6) was photolabelled with efficiency similar to that of the wild-type enzyme, despite a reduction in specific NADI glycohydrolase activity by a factor of approx. 3. Kinetic measurements using this mutant revealed a 4-fold decrease in the value of the Km for NADI (Table 1) ; however, the value for kc,t was also decreased by 6-fold. The simultaneous decreases in Km and kcat could account for the disparity between the specific enzyme activity and the degree of labelling, and suggests that the removal of the six amino acids immediately preceding the 'homology box' may have the effect of relieving steric or other constraints on NAD+ binding and at the same time decreasing the catalytic efficiency. Replacement of serine-12 Studies using deletions and site-directed mutagenesis have implicated several regions of the S1 subunit of PT in the enzymic mechanism ofADP-ribosylation. Several studies have now shown that deletion or alteration of the N-terminal region that shows identity with that of CT and HLT can significantly diminish the ADP-ribosyltransferase activity of the SI subunit [14] [15] [16] [17] . Chemical modification or mutagenic replacement of Trp-26, the only tryptophan residue in the catalytic domain of the S1 subunit, also results in drastic reductions in enzyme activity [14, 31] . Deletion of Glu-129 or substitution of Glu-129 in the S1 subunit with glycine or aspartic acid results in loss of detectable enzyme activity and has led to the proposal that this residue represents the functional equivalent of Glu-148 of DT and Glu-553 of ETA [17, 31] . A specific role for Glu-129 is also supported by the results of Cockle [25] , who initially showed that this residue was the primary site of photolabelling with radioactive NAD+, and by Barbieri et al. [26] , who demonstrated that substitution of this residue with either glycine or aspartic acid abolished the photolabelling of the S1 subunit. We favour the interpretation that residues within the N-terminal region of sequence similarity in SI are also involved directly in NADI binding. On the basis of our previous observation of the profound effect exerted by the single substitution mutant R9K [15] on both glycohydrolase and transferase activity, we propose that arginine-9 might also be directly involved in NADI binding. This could occur, for example, through ion-pairing between the guanidino group of arginine and the pyrophosphate group of NADI. Other recent findings also support an important role for this residue in the enzymic mechanism. Pizza et al. [32] have recently described mutant versions of intact PT that incorporate single-amino-acid substitutions at several positions in the SI subunit. The substitutions included lysine for arginine-9, leucine for arginine-13 and glycine for glutamic acid-129. Among these mutations, the arginine-9-to-lysine substitution yielded a specific ADPribosyltransferase activity that was less than either of the two other mutants by a factor of 5. This finding suggests that arginine-9 is equally or more important than glutamic acid-129. It is also noteworthy that we have determined that substitution of arginine-9 with a variety of amino acids results in similar decreases in enzymic activity, whereas substitution of arginine-58, which is located in a second region of sequence similarity, or tryptophan-26, results in a significantly lesser decrease [33; Y. Lobet & W. Cieplak, Jr., unpublished work].
The results described herein provide a basis for the mechanistic interpretation of the effects associated with mutagenic alterations in the N-terminal region on the enzymic activities of the S1 subunit ofPT, and support the proposal that mutagenic alteration of this region will be useful in the construction of a non-toxic, but immunogenic, recombinant holotoxin, like those described recently by Pizza et al. [32] for vaccine use.
